Patent classifications
C07K16/34
HLA binding vaccine moieties and uses thereof
The present invention relates to an immunoglobulin derived single-chain fragment variable (scFv) that broadly binds HLA II molecules and uses thereof. In particular, targeting of an antigen to antigen presenting cells with the HLAII-specific targeting unit provided herein find use in enhancing immune responses after vaccination.
Affinity chromatography media for removal of anti-a and/or anti-b antibodies
Embodiments described herein relate to novel chromatography media for removing anti-A and/or anti-B antibodies from a sample, as well as methods of using the same. The media described herein have several advantages over previously described media including, acid and alkaline stability.
Affinity chromatography media for removal of anti-a and/or anti-b antibodies
Embodiments described herein relate to novel chromatography media for removing anti-A and/or anti-B antibodies from a sample, as well as methods of using the same. The media described herein have several advantages over previously described media including, acid and alkaline stability.
SICKLED BETA GLOBIN ANTIBODIES
The invention provides anti-.sup.S globin antibodies or antigen binding fragments thereof.
SICKLED BETA GLOBIN ANTIBODIES
The invention provides anti-.sup.S globin antibodies or antigen binding fragments thereof.